山东威高集团医用高分子制品股份有限公司（威高股份，股票代码：01066）于2026年6月22日进行股份回购，共计回购普通股H股280,000股，占当日公司现有已发行股本约0.0063%。回购价格区间每股港币3.16元至3.19元，合计耗资888,200港元（折合约88.82万港元）。
本次回购完成后，公司已发行股本（不含库藏股）为4,462,777,924股，库存股份增至59,554,400股，总体已发行股本仍为4,522,332,324股。公司已于2026年5月29日通过购回授权决议，可回购股份总数为446,464,632股。截至目前，公司合计回购2,228,400股，占购回授权通过当日已发行股本约0.4991%。
公司在公告中确认已遵守香港联交所相关上市规则以及适用法律法规。本公告由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.